Israel Active

13 year-old Mohammed Abu Jazer from Gaza got a new lease on life when surgeons from Israel’s voluntary humanitarian organization Save a Child's Heart in Holon implanted an Israeli pulmonary valve. The Medronic Melody device will improve blood flow and help him avoid future surgeries.

A study by Israel’s EarlySense has shown that the unresolved respiratory problems of heart patients was the most significant cause of their readmission to hospital.  EarlySense’s “under the mattress” device monitors a patient’s breathing amongst many other factors.

Researchers at Tel Aviv University have developed tests to highlight the different rates people recover from stress.  The study can help individuals to train themselves to relax.  It also may lead to a blood test that can diagnose undue stress and help with the recovery process.

Israel’s MobileODT demonstrated its life-saving smartphone technology to detect cervical cancer at the Innovation Showcase at this year’s AIPAC Conference.  Launched only last May it has been used 6000 times in 20 countries.

Israel’s Rosetta Genomics has announced that its RosettaGX Reveal diagnostic test for thyroid cancer is now approved for use in all 50 US states.

Israel’s BioLight Life Sciences has completed a successful U.S. clinical study designed to assess the effectiveness of its TeaRx multi-assay test in evaluating tears’ components of patients suffering from dry eye syndrome (DES) as well as those of healthy subjects.

Israel’s Hospitech Respiration has received US FDA clearance for its AnapnoGuard 100 intubation system.  AnapnoGuard is already CE2 cleared.  More than 100 million patients annually require manual ventilation - the largest reason for admission into intensive care.

Currently it is not possible to freeze organs in order to preserve them for later transplant. Now researchers at the Hebrew University of Jerusalem have studied ice-binding “antifreeze proteins” that protect frozen cells from expansion damage when they thaw out.

Israel’s Amir Goldenthal began his PhD when he was 16 and just one year into his first degree. Now 19, his doctoral dissertation involves breakthroughs in the understanding of neurological diseases such as epilepsy, Alzheimer's and Parkinson's. Amir won a prize at the Nobel Laureates Conference in Japan for best research paper.

Here is a video to demonstrate the power of the portable ultrasound device developed in the laboratory of Israel Technion’s Professor Yonina Eldar.